Our current findings support the therapeutic value of JAT for ameliorating diabetes-related endothelial dysfunction by upregulating the Akt/eNOS pathway to increase NO bioavailability, accomplished with inhibition of ER stress and oxidative stress in vitro and in vivo. Here, AKT1 is linked to endothelial dysfunction.